文献速递产科

门诊宫颈成熟与引产采用小剂量阴道米索前列醇可缩短至分娩时间:一项系统评价与网状Meta分析

Outpatient cervical ripening and labor induction with low-dose vaginal misoprostol reduces the interval to delivery: a systematic review and network meta-analysis.
PubMed 文献 · Am J Obstet Gynecol · 2023-07-18

该系统评价与网状Meta分析纳入42项随机对照试验共6093名参与者,比较门诊宫颈成熟方法的有效性与安全性。结果显示25μg阴道米索前列醇在缩短干预至分娩时间上最有效(累积排序曲线下面积1.0),且不增加剖宫产、额外成熟方法需求、低Apgar评分或子宫过度刺激的几率。

要点

  • 25μg阴道米索前列醇在缩短至分娩时间上最有效(累积排序曲线下面积1.0)。
  • 25μg阴道米索前列醇不增加剖宫产、额外成熟方法需求、低Apgar评分或子宫过度刺激的几率。
  • 50mg口服米非司酮在有效方法中剖宫产几率最低(累积排序曲线下面积0.9)。

核心结论

  • 平衡有效性与安全性,25μg阴道米索前列醇是门诊宫颈成熟的最佳方法。

研究设计与样本

  • 系统评价与网状Meta分析,纳入42项随机对照试验共6093名参与者,检索MEDLINE、Embase、Scopus、Web of Science、Cochrane Library和ClinicalTrials.gov自建库至2020年1月14日。

主要发现

  • 25μg阴道米索前列醇在缩短干预至分娩时间上最有效,累积排序曲线下面积1.0,且不增加剖宫产、额外成熟方法需求、低Apgar评分或子宫过度刺激的几率。
  • 指压法(累积排序曲线下面积0.3)和月见草油(累积排序曲线下面积0.2)在缩短至分娩时间上效果最差。
  • 有效方法中,50mg口服米非司酮与最低剖宫产几率相关(累积排序曲线下面积0.9)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Several systematic reviews and meta-analyses have summarized the evidence on the efficacy and safety of various outpatient cervical ripening methods. However, the method with the highest efficacy and safety profile has not been determined conclusively. We performed a systematic review and network meta-analysis of published randomized controlled trials to assess the efficacy and safety of cervical ripening methods currently employed in the outpatient setting. DATA SOURCES: With the assistance of an experienced medical librarian, we performed a systematic search of the literature using MEDLINE, Embase, Scopus, Web of Science, Cochrane Library, and ClinicalTrials.gov. We systematically searched electronic databases from inception to January 14, 2020. STUDY ELIGIBILITY CRITERIA: We considered randomized controlled trials comparing a variety of methods for outpatient cervical ripening. METHODS: We conducted a frequentist random effects network meta-analysis employing data from randomized controlled trials. We performed a direct, pairwise meta-analysis to compare the efficacy of various outpatient cervical ripening methods, including placebo. We employed ranking strategies to determine the most efficacious method using the surface under the cumulative ranking curve; a higher surface under the cumulative ranking curve value implied a more efficacious method. We assessed the following outcomes: time from intervention to delivery, cesarean delivery rates, changes in the Bishop score, need for additional ripening methods, incidence of Apgar scores <7 at 5 minutes, and uterine hyperstimulation. RESULTS: We included data from 42 randomized controlled trials including 6093 participants. When assessing the efficacy of all methods, 25 μg vaginal misoprostol was the most efficacious in reducing the time from intervention to delivery (surface under the cumulative ranking curve of 1.0) without increasing the odds of cesarean delivery, the need for additional ripening methods, the incidence of a low Apgar score, or uterine hyperstimulation. Acupressure (surface under the cumulative ranking curve of 0.3) and primrose oil (surface under the cumulative ranking curve of 0.2) were the least effective methods in reducing the time to delivery interval. Among effective methods, 50 mg oral mifepristone was associated with the lowest odds of cesarean delivery (surface under the cumulative ranking curve of 0.9). CONCLUSION: When balancing efficacy and safety, vaginal misoprostol 25 μg represents the best method for outpatient cervical ripening.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Vilchez G, Meislin R, Lin L, et al. Outpatient cervical ripening and labor induction with low-dose vaginal misoprostol reduces the interval to delivery: a systematic review and network meta-analysis. Am J Obstet Gynecol. 2023. PMID: 38462254. doi:10.1016/j.ajog.2022.09.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。